OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
19
Results
Show all
Save search
Copy query
Show results for
Unknown
(19)
Publication Date
Release Date
2015
(5)
2021
(4)
2022
(3)
2024
(2)
2023
(2)
2025
(1)
2018
(1)
2017
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci.
Not available
S-EPMC5318969
|
biostudies-literature
Cite
Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility.
Not available
S-EPMC6034790
|
biostudies-literature
Cite
Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study.
Not available
S-EPMC4892108
|
biostudies-literature
Cite
Genome-wide significant risk associations for mucinous ovarian carcinoma.
Not available
S-EPMC4520768
|
biostudies-literature
Cite
Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer.
Not available
S-EPMC4635670
|
biostudies-literature
Cite
Shared genetics underlying epidemiological association between endometriosis and ovarian cancer.
Not available
S-EPMC4581608
|
biostudies-literature
Cite
A multi-country test of brief reappraisal interventions on emotions during the COVID-19 pandemic.
Not available
S-EPMC8742248
|
biostudies-literature
Cite
Identification of six new susceptibility loci for invasive epithelial ovarian cancer.
Not available
S-EPMC4445140
|
biostudies-literature
Cite
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355
|
biostudies-literature
Cite
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
Not available
S-EPMC8121538
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets